| Dr Shonda M Corbett, MD | |
|
718 Teaneck Rd Ste 301, Teaneck, NJ 07666-4245 | |
| (551) 288-1025 | |
| Not Available |
| Full Name | Dr Shonda M Corbett |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 25 Years |
| Location | 718 Teaneck Rd Ste 301, Teaneck, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336140029 | NPI | - | NPPES |
| 02461585 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 228897 (New York) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 25MA09967200 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Holy Name Medical Center | Teaneck, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Excelcare Medical Associates Pa | 4284647868 | 182 |
News Archive
"Over-consumption in rich countries and rapid population growth in the poorest both need to be tackled to put society on a sustainable path," according to a report by an expert group convened by the Royal Society, BBC News reports.
Military veterans are more likely to report delays in seeking necessary healthcare, compared to the US general population, reports a study in the Journal of Public Health Management and Practice. The journal is published by Wolters Kluwer.
libragen, a contract research organization dedicated to biocatalysis and metagenomics, has been a major contributor to the success of PolyModE (Polysaccharide Modifying Enzymes), a large collaborative research project funded by the European Community. The project, which began in 2009 and ended in April this year, looked at developing novel polysaccharide modifying enzymes for the optimized use of hydrocolloids as, for example, food additives or novel therapeutic agents in the food sciences and medical industries. Researchers focused on six industry-targeted hydrocolloids (alginates, carrageenans, chitosans, glycosaminoglycans, pectins, and xanthan gums) where traditional chemistry fails to achieve a certain desired modification.
Vasogen has announced a collaboration with Grupo Ferrer Internacional, S.A. ("Ferrer"), to commercialize Vasogen's Celacade technology for the treatment of chronic heart failure in the European Union and in certain Latin American countries.
Graphene nanoribbons (GNRs) bend and twist easily in solution, making them adaptable for biological uses like DNA analysis, drug delivery and biomimetic applications, according to scientists at Rice University.
› Verified 1 days ago
| Entity Name | Excelcare Medical Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992736300 PECOS PAC ID: 4284647868 Enrollment ID: O20060727000044 |
News Archive
"Over-consumption in rich countries and rapid population growth in the poorest both need to be tackled to put society on a sustainable path," according to a report by an expert group convened by the Royal Society, BBC News reports.
Military veterans are more likely to report delays in seeking necessary healthcare, compared to the US general population, reports a study in the Journal of Public Health Management and Practice. The journal is published by Wolters Kluwer.
libragen, a contract research organization dedicated to biocatalysis and metagenomics, has been a major contributor to the success of PolyModE (Polysaccharide Modifying Enzymes), a large collaborative research project funded by the European Community. The project, which began in 2009 and ended in April this year, looked at developing novel polysaccharide modifying enzymes for the optimized use of hydrocolloids as, for example, food additives or novel therapeutic agents in the food sciences and medical industries. Researchers focused on six industry-targeted hydrocolloids (alginates, carrageenans, chitosans, glycosaminoglycans, pectins, and xanthan gums) where traditional chemistry fails to achieve a certain desired modification.
Vasogen has announced a collaboration with Grupo Ferrer Internacional, S.A. ("Ferrer"), to commercialize Vasogen's Celacade technology for the treatment of chronic heart failure in the European Union and in certain Latin American countries.
Graphene nanoribbons (GNRs) bend and twist easily in solution, making them adaptable for biological uses like DNA analysis, drug delivery and biomimetic applications, according to scientists at Rice University.
› Verified 1 days ago
| Entity Name | Valley Physician Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467815928 PECOS PAC ID: 3577857333 Enrollment ID: O20160802002824 |
News Archive
"Over-consumption in rich countries and rapid population growth in the poorest both need to be tackled to put society on a sustainable path," according to a report by an expert group convened by the Royal Society, BBC News reports.
Military veterans are more likely to report delays in seeking necessary healthcare, compared to the US general population, reports a study in the Journal of Public Health Management and Practice. The journal is published by Wolters Kluwer.
libragen, a contract research organization dedicated to biocatalysis and metagenomics, has been a major contributor to the success of PolyModE (Polysaccharide Modifying Enzymes), a large collaborative research project funded by the European Community. The project, which began in 2009 and ended in April this year, looked at developing novel polysaccharide modifying enzymes for the optimized use of hydrocolloids as, for example, food additives or novel therapeutic agents in the food sciences and medical industries. Researchers focused on six industry-targeted hydrocolloids (alginates, carrageenans, chitosans, glycosaminoglycans, pectins, and xanthan gums) where traditional chemistry fails to achieve a certain desired modification.
Vasogen has announced a collaboration with Grupo Ferrer Internacional, S.A. ("Ferrer"), to commercialize Vasogen's Celacade technology for the treatment of chronic heart failure in the European Union and in certain Latin American countries.
Graphene nanoribbons (GNRs) bend and twist easily in solution, making them adaptable for biological uses like DNA analysis, drug delivery and biomimetic applications, according to scientists at Rice University.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Shonda M Corbett, MD 3 University Plz Ste 205, Hackensack, NJ 07601-6208 Ph: (201) 833-3000 | Dr Shonda M Corbett, MD 718 Teaneck Rd Ste 301, Teaneck, NJ 07666-4245 Ph: (551) 288-1025 |
News Archive
"Over-consumption in rich countries and rapid population growth in the poorest both need to be tackled to put society on a sustainable path," according to a report by an expert group convened by the Royal Society, BBC News reports.
Military veterans are more likely to report delays in seeking necessary healthcare, compared to the US general population, reports a study in the Journal of Public Health Management and Practice. The journal is published by Wolters Kluwer.
libragen, a contract research organization dedicated to biocatalysis and metagenomics, has been a major contributor to the success of PolyModE (Polysaccharide Modifying Enzymes), a large collaborative research project funded by the European Community. The project, which began in 2009 and ended in April this year, looked at developing novel polysaccharide modifying enzymes for the optimized use of hydrocolloids as, for example, food additives or novel therapeutic agents in the food sciences and medical industries. Researchers focused on six industry-targeted hydrocolloids (alginates, carrageenans, chitosans, glycosaminoglycans, pectins, and xanthan gums) where traditional chemistry fails to achieve a certain desired modification.
Vasogen has announced a collaboration with Grupo Ferrer Internacional, S.A. ("Ferrer"), to commercialize Vasogen's Celacade technology for the treatment of chronic heart failure in the European Union and in certain Latin American countries.
Graphene nanoribbons (GNRs) bend and twist easily in solution, making them adaptable for biological uses like DNA analysis, drug delivery and biomimetic applications, according to scientists at Rice University.
› Verified 1 days ago
Dr. Sharyn N. Lewin, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 718 Teaneck Rd, Teaneck, NJ 07666 Phone: 201-227-6200 Fax: 201-227-6209 | |
Bryan Alcides Pablo, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 718 Teaneck Rd, Teaneck, NJ 07666 Phone: 201-968-1800 Fax: 201-968-1814 | |
Daniel H. Smith, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 718 Teaneck Road, Holy Name Medical Center, Regional Cancer Center, Teaneck, NJ 07666 Phone: 201-227-6065 Fax: 201-227-6295 | |
Jason Nick Kanos, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 718 Teaneck Rd, Teaneck, NJ 07666 Phone: 201-833-3000 | |
Kimberly L. Fallon, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 718 Teaneck Rd Ste 301, Teaneck, NJ 07666 Phone: 551-288-1025 | |
Mrs. Paula Maria Barcia-pena, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 222 Cedar Lane, Suite 207, Teaneck, NJ 07666 Phone: 201-833-7087 Fax: 201-833-7123 |